Scr-IN-2
Scr-IN-2 is an effective c-Scr inhibitor with an IC50 of 302 nM. Scr-IN-2 exhibits nanomolar-level anti-breast cancer activity. Scr-IN-2 increases the level of ROS in cells, induces mitochondrial damage, G1 phase arrest, and apoptosis. Scr-IN-2 can be used in the research of breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2787582-78-7
- Formule: C21H33N7
- Masse moléculaire:383.53
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Scr-IN-2 (Compound 3g) inhibits MDAMB-231, T47D, and MCF-7 cell proliferation with IC50s of 0.812, 1.03 and 0.568 μM, and shows no significant toxicity to normal breast cells (MCF-10A)[1].
Scr-IN-20 (500 nM, 48 h) increases the ROS production, causes damage to mitochondria, induces apoptosis and halts the cell cycle at the G1 phase in the MCF-7 cells [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 cells
-
Concentration:500 nM
-
Incubation Time:48 h
-
Result:Reached the proportion of apoptotic cells by 62.5%.
-
Cell Line:MCF-7 cells
-
Concentration:500 nM
-
Incubation Time:48 h
-
Result:Blocked MCF-7 cells in the G1 phase to inhibit DNA replication and cell proliferation.
Chemical Information
-
CAS No. 2787582-78-7
-
Masse moléculaire 383.53
-
Formule C21H33N7
-
SMILES
CCCCN1C(NC(C)(C)C)=NC2=CC=CC=C2C1C3=NN=NN3C(C)(C)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz